On this page
Glaucoma (primary open-angle)
POAG is a common cause of irreversible vision loss in adults, often without noticeable symptoms in its early stages. It commonly affects individuals over 40 years old, with both genetic and environmental factors playing a role in its development.
Overview
Primary open-angle glaucoma (POAG) is a chronic eye disease that damages the optic nerve, which transmits visual information from the eye to the brain [PMID:33678089]. This damage can lead to a gradual loss of vision, beginning with peripheral (side) vision and potentially progressing to central vision if left untreated. POAG is called 'open-angle' because the drainage angle within the eye, which is responsible for fluid outflow, appears open and normal upon examination. Despite this, fluid drainage is impaired in POAG, leading to a build-up of pressure inside the eye, known as intraocular pressure (IOP), which can harm the delicate optic nerve [PMID:33678089].
POAG is often referred to as a 'silent thief of sight' because it typically progresses slowly and painlessly, with early vision changes often going unnoticed by the affected individual. Regular eye examinations are crucial for early detection, especially for those with risk factors.
Symptoms & clinical features
In its early stages, primary open-angle glaucoma usually does not have noticeable symptoms. Vision loss typically begins in the peripheral areas, meaning side vision starts to diminish first. This gradual loss can often go undetected as the brain may compensate for missing visual fields, and the individual may adjust without realising the extent of the change [PMID:36014493].
As the condition progresses, the field of vision may narrow further, leading to 'tunnel vision'. In advanced stages, central vision can also be affected, severely impacting daily activities. Unlike some other eye conditions, POAG rarely causes pain unless intraocular pressure becomes very high very quickly, which is uncommon in this specific type of glaucoma. Regular comprehensive eye checks, including pressure measurement and optic nerve assessment, are therefore vital for early diagnosis.
Video: Genetics 101
Affected organs
Primary open-angle glaucoma primarily affects the eyes. Within the eye, the most critical structure impacted is the optic nerve. This nerve is a bundle of nerve fibres that carries visual signals from the retina to the brain. Damage to these fibres, often due to sustained or elevated intraocular pressure, is the hallmark of POAG.
Over time, the consistent pressure can compress and injure the nerve fibres, leading to their degeneration. This damage is irreversible and results in the characteristic vision loss associated with the condition. The retina, specifically the ganglion cells, also experiences damage as their axons form the optic nerve. The front of the eye, including structures like the trabecular meshwork (involved in fluid drainage), may show subtle abnormalities but generally appears normal, hence the term 'open-angle'.
Risks & severity
The severity of primary open-angle glaucoma can range from mild, well-managed forms to severe vision impairment. The progression rate varies significantly among individuals. Risk factors for developing POAG include increasing age, particularly over 40, and a family history of the condition. African or Afro-Caribbean ancestry and extreme short-sightedness (myopia) are also associated with a higher risk [PMID:36014493].
Around 2% of people over 40 in the UK are estimated to have POAG. Without treatment, the condition can lead to significant and irreversible vision loss, eventually causing blindness. Timely diagnosis and ongoing management are crucial in slowing its progression and preserving vision. The disease typically progresses gradually over years.
Genetic causes
Primary open-angle glaucoma is a complex condition with both genetic and environmental factors contributing to its development. It is described as having a polygenic inheritance pattern, meaning multiple genes, along with lifestyle and other factors, influence an individual's risk. Several genes have been identified that are associated with an increased susceptibility to POAG.
Among the genes that have been studied regarding POAG, MYOC (myocilin), OPTN (optineurin), and WDR36 (WD repeat domain 36) are notable. Pathogenic changes in the MYOC gene, for instance, are implicated in a subset of POAG cases, particularly those with a strong family history and earlier onset [PMID:36014493]. Mutations in OPTN are associated with a form of POAG that may occur with normal intraocular pressure [PMID:30154010]. WDR36 is also thought to play a role in the cellular processes within the eye that influence glaucoma risk. These genetic associations help us understand the biological mechanisms underlying POAG, but they do not explain all cases, reflecting the polygenic nature of the disease.
Inheritance pattern
Primary open-angle glaucoma typically follows a polygenic or complex inheritance pattern. This means that changes in multiple genes, rather than a single gene, contribute to an individual's susceptibility. Additionally, non-genetic factors, such as age, ethnicity, and other medical conditions, interact with these genetic predispositions to determine who develops POAG and its severity.
If a close relative, such as a parent or sibling, has POAG, an individual's risk of developing the condition is higher than that of the general population. However, it's not guaranteed that you will develop POAG even with a family history. Genetic testing might identify specific risk factors, but it usually doesn't provide a definitive 'yes' or 'no' answer for developing the condition due to its complex inheritance. Recommendations for relatives usually involve regular eye screenings starting at an earlier age.
Diagnosis & testing
Diagnosing primary open-angle glaucoma involves a comprehensive eye examination by an ophthalmologist or optometrist. This typically includes measuring the intraocular pressure (IOP), examining the optic nerve for damage (often with imaging techniques like optical coherence tomography, OCT), and performing a visual field test to check for peripheral vision loss. The front structures of the eye, particularly the drainage angle, are also inspected to confirm the 'open-angle' type of glaucoma.
Genetic testing is not routinely used to diagnose POAG in the general population, but it may be considered in specific circumstances, such as cases with a very strong family history, early onset, or when certain genetic risk factors are suspected. Referral for genetic testing for POAG in the NHS would typically come from an ophthalmologist or a clinical geneticist. There are relevant NHS 'R-codes' for diagnostic testing panels that include genes associated with glaucoma where appropriate, often under the 'Eye disorders' category.
Management & lifestyle
The primary goal of managing primary open-angle glaucoma is to lower intraocular pressure (IOP) to prevent further damage to the optic nerve and preserve vision. While existing nerve damage cannot be reversed, treatment can slow or halt the progression of the disease. Management strategies are individualised and depend on the stage of glaucoma, the level of IOP, and other patient-specific factors.
Initial treatment often involves eye drops that help reduce IOP by either decreasing fluid production within the eye or increasing fluid outflow. If eye drops are insufficient or not tolerated, other options include laser treatment (e.g., selective laser trabeculoplasty) to improve drainage, or surgical procedures (e.g., trabeculectomy) to create a new drainage pathway [PMID:37552909]. Regular monitoring with follow-up eye examinations, including IOP measurements, optic nerve assessments, and visual field tests, is essential to adjust treatment as needed and detect any progression. Adherence to prescribed treatments is key for successful long-term management.
UK care pathway
In the UK, individuals suspected of having primary open-angle glaucoma are typically referred by their optometrist or GP to an ophthalmologist within the NHS. The ophthalmologist will conduct a full diagnostic assessment and initiate a management plan. Genetic counselling might be offered through NHS Clinical Genetics services if there is a strong family history or other features suggesting a specific genetic cause, where a referral can be made by the ophthalmologist. Relevant genomic testing, if indicated, would fall under the NHS Genomic Medicine Service's National Genomic Test Directory, grouped under appropriate R-codes for eye disorders.
Frequently asked questions
Can primary open-angle glaucoma be cured?
No, primary open-angle glaucoma cannot be cured, and optic nerve damage cannot be reversed. However, treatment can effectively manage the condition, slow down its progression, and help preserve remaining vision by controlling intraocular pressure.
How often should I have my eyes checked if I have a family history of POAG?
If you have a close relative with POAG, it is generally recommended to start regular comprehensive eye examinations earlier than the general population, perhaps from around age 40, or even earlier if advised by an ophthalmologist. Your optometrist or GP can provide specific guidance.
Will I go blind if I have primary open-angle glaucoma?
Not necessarily. With early diagnosis and consistent, appropriate treatment, most people with primary open-angle glaucoma can maintain their vision and prevent severe vision loss or blindness. Regular follow-up appointments and adherence to treatment are crucial.
Are lifestyle changes helpful for managing POAG?
While lifestyle changes alone cannot cure POAG or replace medical treatment, some evidence suggests that certain healthy habits, such as regular moderate exercise, maintaining a healthy weight, and a balanced diet, might support overall eye health. Always discuss any lifestyle changes with your healthcare team.
What is the typical age for POAG to be diagnosed?
Primary open-angle glaucoma is most commonly diagnosed in individuals over the age of 40, with the risk increasing significantly with age. However, some forms can appear earlier, particularly if there is a strong genetic predisposition.
References
- Gupta D, Chen PP. Glaucoma. American family physician. 2016. PMID: 27175839
- Coleman AL. Glaucoma. Lancet (London, England). 1999. PMID: 10577657
- Dietze J, Blair K, Zeppieri M. Glaucoma (Nursing). 2026. PMID: 33760507
- Zukerman R, Harris A, Oddone F. Glaucoma Heritability: Molecular Mechanisms of Disease. Genes. 2021. PMID: 34440309
- Ray K, Mookherjee S. Molecular complexity of primary open angle glaucoma: current concepts. Journal of genetics. 2009. PMID: 20090207
- Kocatürk T, Akgüllü Ç, Evliçoğlu GE. Diurnal blood pressure parameters in normal tension glaucoma, primary open angle glaucoma, and healthy subjects. Anatolian journal of cardiology. 2017. PMID: 28315568
- George R, Panda S, Vijaya L. Blindness in glaucoma: primary open-angle glaucoma versus primary angle-closure glaucoma-a meta-analysis. Eye (London, England). 2022. PMID: 34645961
- Chakraborty S, Mookherjee S, Sen A. Analysis of COCH and TNFA variants in East Indian primary open-angle glaucoma patients. BioMed research international. 2013. PMID: 24063017